Waverly Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Buy
32,751
+3,009
+10% +$370K 0.03% 479
2026
Q1
$3.5M Sell
29,742
-1,070
-3% -$149K 0.03% 504
2025
Q4
$5.05M Buy
30,812
+375
+1% +$58.7K 0.04% 374
2025
Q3
$4.07M Buy
30,437
+10,105
+50% +$1.23M 0.04% 356
2025
Q2
$2.53M Sell
20,332
-100
-0.5% -$12.7K 0.03% 448
2025
Q1
$2.6M Buy
+20,432
New +$3.15M 0.03% 426

Other funds holding RGEN

Waverly Advisors's RGEN Position: Q2 2026 in Review

Waverly Advisors increased its Repligen (RGEN) stake by 10% in Q2 2026, buying an estimated $370K and bringing the position to 32,751 shares worth $4.47M. The position accounts for 0.03% of the portfolio, ranked #479.

Waverly Advisors first reported a position in RGEN in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.05M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Waverly Advisors held 32,751 shares of Repligen worth $4.47M as of Q2 2026.
  • Waverly Advisors bought 3,009 Repligen shares in Q2 2026, an estimated $370K.
  • Repligen made up 0.03% of Waverly Advisors's portfolio in Q2 2026, its #479 holding.
  • Waverly Advisors first reported a position in Repligen in Q1 2025 and has held it in 6 quarters since.
  • Waverly Advisors's Repligen position peaked at $5.05M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.